Adjuvo
Angel networkLondon · Seed–Series A · 32 people tracked
Investment thesis
Adjuvo operates as an investor syndicate/network that connects its members — described as leaders across many industries — with early-stage private companies seeking capital. The firm sources and evaluates deal flow, conducts due diligence, and facilitates investments by members into portfolio companies, then supports those companies through portfolio management, shareholder communications, and network activations. It works within UK tax-advantaged frameworks such as EIS and SEIS and uses third-party fund administration. Its portfolio spans healthtech/medtech, foodtech, robotics, cleantech, mobility, retail technology, proptech, fintech, and consumer brands, reflecting a broadly sector-agnostic approach centred on backing British innovators and disruptive technologies.
Source: firm website, verified Aug 2, 2026.
Team · 32 people
from the firm's websiteCo-founding Partner of Adjuvo with a twenty-year track record in executive search across financial services. He co-founded Rice & Dore Associates in 1997 and holds a BA in Business Studies from Sheffield Hallam University.
Co-founding partner of Adjuvo with a long career in executive search across financial services; co-founded Rice & Dore Associates in 1997.
CEO and Co-Founding Partner of Adjuvo with a 38-year track record across financial markets and the investment process. He held senior roles at James Capel, Morgan Grenfell/Deutsche Bank, and helped establish Altima Partners LLP.
CEO and co-founding partner of Adjuvo with a 38-year track record across financial markets and the investment process, having held senior roles at James Capel, Morgan Grenfell/Deutsche Bank and Altima Partners.
Chairman and founding shareholder of Adjuvo with roles including the Pension Insurance Corporation Investment Committee and directorships at AYR and Cycle Pharmaceuticals. A Cambridge economics graduate and chartered accountant, he held senior roles at banks including Salomon Brothers and served as Bursar at Robinson College Cambridge.
Chairman and founding shareholder of Adjuvo, a chartered accountant with senior banking roles at Salomon Brothers and others, and former Bursar at Robinson College Cambridge.
Manages relationships within the Adjuvo syndicate, introducing investment opportunities to members and overseeing portfolio company interactions. Joined Adjuvo in 2015 as an Associate; previously worked at Human Capital and Goodman Masson.
Manages relationships within the Adjuvo syndicate and introduces investment opportunities to members; joined in 2015 as an Associate and contributes to overall strategy at board level.
Oversees all new investment opportunities at Adjuvo, working with Charlotte on deal flow, evaluation, origination, and due diligence. Formally joined in February 2022 (a member since 2019) after a 30-year career as a Managing Director in the equity division of Bank of America Merrill Lynch.
Oversees all new investment opportunities and manages deal flow; joined Adjuvo formally in February 2022 after being a member since 2019. Previously a Managing Director in the equity division of Bank of America Merrill Lynch.
Responsible for portfolio management, reporting, and shareholder communications, having joined Adjuvo in December 2021 as an Associate Director. Previously spent three years at Seedrs and two at Funding Circle; studied Theology at Bristol University.
Director responsible for investor relations, portfolio operations, and identifying growth opportunities. Previously established an Innovation Lab for Publicis Groupe in Silicon Valley and served as Head of Growth for Gary Vaynerchuk.
Board Director who was Chairman and CEO of PGIM Quant Solutions (2017-2022) and previously held senior distribution roles at AMG, BlackRock and Merrill Lynch Investment Managers.
Manages the syndicate's deal flow with Philip, handling evaluation, deal origination, due diligence, and analysis, having joined as an Analyst in February 2021. Previously a Graduate Analyst at J.P. Morgan; holds an MSt in History from Oxford.
Manages deal flow, evaluation, deal origination and due diligence, joining Adjuvo in February 2021 as an Analyst. Previously a Graduate Analyst at J.P. Morgan.
Joined Adjuvo in August 2022 as an Associate focused on portfolio community building, network activations, and membership engagement. Previously worked in behavioural science research, business development, and as a legal assistant; holds a BSc in Psychology from the University of Bath.
Joined Adjuvo in August 2022 as an Associate handling portfolio community-building, communications and membership engagement. Previously worked in behavioural science research, business development and as a legal assistant.
Director and Company Secretary responsible for the end-to-end investment process and the relationship with custodian Thompson Taraz, plus compliance and due diligence. Holds a BA in Geography and Economics from Durham University.
Director and Company Secretary at Adjuvo managing the investment process and the relationship with custodian Thompson Taraz, plus compliance and due diligence. Previously worked at a strategy consultancy and a fintech startup.
CFO of Adjuvo since September 2022, with expertise in financial, regulatory, and operational issues facing investment firms. A Chartered Accountant, he was previously Group CFO at Baring Private Equity Partners and a partner at Altima Partners LLP.
CFO of Adjuvo since September 2022 with expertise in financial, regulatory and operational issues for investment firms. Previously Group CFO at Baring Private Equity Partners and a partner at Altima Partners.
Responsible for driving new business, cultivating investor relationships, and supporting interactions between Adjuvo's portfolio companies and syndicate members. A former network member, he formally joined Adjuvo in 2026 after an earlier career as a junior equities broker and later as a psychotherapist and NLP practitioner.
Responsible for new business, investor relationships and connecting portfolio companies with syndicate members; a former network member who joined Adjuvo in June 2026. Previously a junior equities broker at Kyte Broking and later a psychotherapist and NLP practitioner running his own London practice.
Listed as CEO in association with the NoBACZ portfolio company profile.
Joined Adjuvo in September 2024 as Office Manager, handling diary management and office operations. Previously an Account Coordinator at advertising agency VCCP; holds a BA in Media, Journalism and Publishing from Oxford Brookes University.
Joined Adjuvo in September 2024 as Office Manager, handling diary management and office operations. Previously an Account Coordinator at advertising agency VCCP.
Responsible for portfolio management, reporting and shareholder communications; joined Adjuvo in December 2021 as an Associate Director. Previously worked at Seedrs and Funding Circle.
Director focused on investor relations, portfolio operations and growth opportunities. Previously ran an innovation lab for Publicis Groupe in Silicon Valley and led growth for Gary Vaynerchuk.
Joined Adjuvo in November 2022 as an Associate, supporting the investment process, compliance, and the relationship with custodian Thompson Taraz. Previously an operations analyst at Kneip and a junior project manager at insurtech startup Symfos; holds a BA in History from Manchester.
Joined Adjuvo in November 2022 as an Associate supporting the investment process, compliance and due diligence. Previously an operations analyst at Kneip and project manager at insurtech startup Symfos.
A marketing and communications consultant who supports Adjuvo's management on community building and membership engagement. She has worked in marketing and PR for British retailers including Selfridges and founded her own communications consultancy in 2018.
A communications consultant supporting Adjuvo's marketing, community-building and events. Spent her career in marketing and PR at British retailers such as Selfridges and Watches of Switzerland before founding her own consultancy.
Investments · 29 tracked
founders shown can be your intro pathUK technology company developing vaporiser solutions for a nicotine-free future.
AI-enabled board evaluation software producing actionable governance reports.
Carbon-negative fertiliser produced from organic waste streams.
Blockchain-based authorised signatory management platform.
Next-generation bio-based autoinjector with greater production capacity, lower cost and reduced carbon footprint.
Digital system of record for the global brand licensing industry, turning licensing data into verifiable digital credentials.
Fuel delivery technology that improves diesel engine efficiency and reduces emissions.
Curated rental platform connecting first-time renters and pre-vetted tenants with landlords.
Clinician-led healthcare technology improving safety and comfort for IV therapy and haemodialysis patients.
World's largest structured dataset of merchant offers, deals and coupons powering AI shopping.
Savile Row tailor specialising in bespoke and made-to-measure tailoring exclusively for women.
Travel company providing accessible holiday experiences and care packages for people with disabilities.
Lightweight bike locks armoured with Barronium composite resistant to angle grinders.
Free-roam virtual reality entertainment arenas across multiple UK venues.
Food technology company making ultra-processed foods healthier, starting with SUPERLOAF bread.
Develops patented antibiotic-free, biodegradable 'liquid bandages' for animal wound care that form a protective barrier over skin to block microbes, repel water, and support natural healing.
Antibiotic-free, biodegradable 'liquid bandages' for animal wound care.
Customer data and cross-channel marketing platform for retailers.
Robotics-as-a-Service solution for underfloor insulation using remote-controlled robots.
MedTech company making rapid, portable point-of-need multiplex PCR diagnostic devices.
Clickable device that converts standard bicycles into electric bikes in minutes.
Retail technology re-engineering receipts into a customer engagement and rewards tool.
Patent-protected Sandwich Plate System composite material replacing stiffened steel and concrete.
Functional high-protein savoury snacks brand for active consumers.
Salary sacrifice scheme making electric car adoption cheaper and simpler.
Media-rich job application platform enabling candidates to showcase talents beyond traditional CVs.
Data platform for forecasting, measuring and optimising influencer marketing performance.
Technology platform matching schools with supply teachers in the UK and US.
White-label SaaS technology powering pay-per-wear fashion rental for retailers.
Frequently asked questions
- What stage does Adjuvo invest at?
- Adjuvo invests at the Seed, Series A stages.
- What sectors does Adjuvo focus on?
- Adjuvo focuses on Cleantech, EdTech, Enterprise Software, FoodTech, Healthtech, Medical Devices, Mobility & Transportation, New Materials, PropTech, Retail Tech, Robotics, Sector Agnostic.
- Where is Adjuvo located?
- Adjuvo is headquartered in London, GB.
Images
Similar investors
Everywhere Ventures is a global pre-seed venture capital firm founded in 2018 and headquartered in New York, investing $250,000 into early-stage technology companies. It runs a community-led model backed by 500+ founder and operator LPs.
MPG Fund is an early-stage investor backing technology startups across a range of sectors.
Norrsken VC is a Stockholm-based venture capital firm that invests in companies solving the world's hardest problems, with a focus on impact-driven startups.
Investible is a global early-stage venture capital firm with offices in Sydney and Singapore that invests in and supports founders building high-growth technology companies. It runs Early Stage Funds and the Investible Climate Tech Fund.
Ventureast is described as one of India's longest standing venture capital firms, investing in companies since the late 1990s.